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Improving cephazolin re-dosing practices
Dr Luke Anderson (John Hunter Hospital, University of 
Newcastle, Newcastle, NSW), Dr Robert Marr (Monash 
Medical Centre, Melbourne, Victoria)  
Introduction: Surgical site infection (SSI) is a common, 
preventable cause of post-operative morbidity. Intraoperative 
re-dosing of cephazolin is recommended for surgical 
procedures extending beyond two half-lives of the drug, to 
decrease the risk of SSI. Failure to re-dose is an independent 
risk factor for the development of SSI. Despite re-dosing 
recommendations, compliance is low, with rates of 20-27% 
reported in the literature. Reminder based interventions have 
improved re-dosing rates from 20% to 58%. Intraoperative 
decision support systems have led to re-dosing rates of 
84-98%. The aim of this project is to improve intraoperative 
cephazolin re-dosing to comply with guidelines 60-80% of the 
time over a 6 month period.
Method: A retrospective audit of anaesthetic records was 
conducted to obtain a baseline rate of re-dosing. This was 
followed by an education-based intervention, consisting of 
guideline dissemination and feedback of audit results. Cases 
performed at John Hunter Hospital from January 1st 2017 to 
January 31st 2017 were audited to produce baseline data. 
The educational intervention occurred in July 2017, and cases 
from 1st August 2017 to 31st August 2017 were audited to 
observe the effect of the intervention. Cases were included 
if an indication for cephazolin prophylaxis was present, 
the patient was 18 years of age or older, and underwent 
a procedure of greater than 3 hours' duration. Cases were 
excluded if therapeutic antibiotics were used, cephazolin 
was not the recommended agent, the patient had a major 
beta-lactam allergy or cardio-pulmonary bypass was used 
(due to prolongation of cephazolin half-life). Sample size 
was calculated to detect a significant change in re-dosing 
practice for subsequent audit cycles. A sample size of 25 
was calculated to give a power of 0.8 and a two-sided alpha 
of 0.05. This sample size was doubled to 50, to increase 
study power. Pearson Chi-square (χ2) test was performed 
to determine any statistically significant difference between 
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groups before and after the intervention.
Results: 50 cases were included in the initial audit. Intra-
operative re-dosing rates were low, with overall compliance 
of 34% in the January period. The target sample size for the 
post-intervention period was unable to be reached due to a 
lack of cases greater than 3 hours' over the audited period. 
42 cases were included in the post-intervention analysis. 
36% of patients received repeat intra-operative dosing when 
indicated in the post-intervention group. There was no 
significant improvement in re-dosing rates post intervention 
[Percentage difference 2%, Chi-squared = 0.04 (95% CI -16.83 
to 21.03, p=0.84)].
Conclusion: There was no significant improvement in intra-
operative cephazolin re-dosing practices with an educational 
intervention based on audit-feedback cycling and guideline 
dissemination. This is consistent with the low efficacy of 
educational interventions seen in the literature. Reminder 
based interventions have been shown to have the greatest 
effect in improving re-dosing rates. This will form the next 
intervention as a part of continued plan-do-study-act (PDSA) 
cycling. Due to the absence of electronic intraoperative 
prescribing at our institution, a smartphone app will be 
developed to deliver reminders to clinicians responsible for 
intra-operative re-dosing.
Improving the Fidelity of Cardiopulmonary Exercise Testing 
(CPET) for Preoperative Risk Assessment in Major Non-
Cardiac Surgery
Dr Jarrod Basto (Peter MacCallum Cancer Centre, University 
of Melbourne, Melbourne, Victoria), Dr Hilmy Ismail (Peter 
MacCallum Cancer Centre, University of Melbourne), Dr 
Michael Li (Peter MacCallum Cancer Centre, University of 
Melbourne), Dr Vladimir Bolshinsky (Peter MacCallum Cancer 
Centre, University of Melbourne), Ms Jamie Waterland (Peter 
MacCallum Cancer Centre, University of Melbourne), Dr 
Alan Herschtal (Peter MacCallum Cancer Centre, University 
of Melbourne), Dr Kate Burbury (Peter MacCallum Cancer 
Centre, University of Melbourne), Professor Alexander Heriot 
(Peter MacCallum Cancer Centre, University of Melbourne), 
Professor Bernhard Riedel (Peter MacCallum Cancer Centre, 
University of Melbourne)
Introduction: The traditional paradigm of preoperative CPET 
assessment, established three decades ago, places oxygen 
consumption (VO2; measured at anaerobic threshold [AT] 
and peak exercise [pVO2]) at the centre of preoperative 
risk prediction. VO2, is traditionally dichotomised (AT <10-
11 mL.kg.min-1 and pVO2 <16 mL.kg.min-1) for ease of 
surgical risk prediction [1]. Despite an increasingly elderly 
population with higher comorbid disease burden, surgical 
and anaesthetic practice continues to evolve and undertake 
more complex surgery within the framework of sub-
specialised care. Within this context, these dichotomised 
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VO2 values may lack diagnostic fidelity to risk-evaluate and 
guide patient optimisation prior to major surgery. In non-
surgical populations, cardiorespiratory disease associates 
with impaired CO2 output [2] and incompetent chronotropic 
response associates with increased mortality. As such, 
we evaluated the utility of: (i) CPET-derived CO2 kinetics 
(PeCO2; PETCO2; Ve/VCO2) and chronotropic response as risk 
predictors for adverse post-operative outcomes; (ii) standard 
blood tests to improve CPET risk modelling.
Methods: We retrospectively analysed 84 patients 
undergoing CPET prior to major colorectal surgery. 
Parameters measured: Demographic data, Charlson 
Comorbidity Index, conventional preop blood tests 
(haemoglobin, WCC, neutrophils, albumin) and CPET-derived 
VO2 (AT, pVO2), VCO2 (VE/VCO2, PETCO2, Pe’CO2), and heart 
rate response (HRR) parameters. Postoperative outcomes 
assessed: (i) Morbidity using Comprehensive Complication 
Index (CCI, which considers all Clavien-Dindo graded 
complications) and (ii) 1-year minimum Overall Survival (OS). 
Statistical methods used univariable Cox proportional hazards 
and linear regression analysis.
Results: Patients (mean±SD) were 62 (±12) years old, 
55% male, 27.8 (±5.6) kg.m-2 BMI and Comprehensive 
Complication Index (30±19). Univariable modelling showed 
no association between traditional VO2 kinetic parameters 
and OS (AT; HR=0.89 [0.72-1.10]; p=0.25); pVO2; HR=0.91 
[0.80-1.04]; p=0.15). Peak VO2 corrected for body surface 
area (pVO2/BSA >710mL.min-1.m-2) associated with 
reduced postoperative morbidity (p=0.019) and improved OS 
(HR=0.13 [0.03-0.56]; p=0.001). VCO2 kinetics at AT (PETCO2; 
HR=0.89 [0.82-0.96]; p=0.004 and PeCO2; HR=0.86 [0.78-
0.95]; p=0.003) and HR response to peak exercise (HR=0.10 
[0.02-0.48]; p=0.02) were robust predictors of OS.  Low 
preoperative haemoglobin (p=0.001) and elevated neutrophil 
levels (p=0.01) associated with reduced OS and morbidity, 
respectively. Using bivariate analysis, predictive accuracy for 
postoperative morbidity and for OS improved significantly 
(p<0.01) if pVO2/BSA considered chronotropic response to 
peak exercise or preoperative neutrophil count and PeCO2 
at AT, neutrophil count for predictive modelling of postop 
morbidity and OS, respectively. 
Conclusions: Traditional CPET-derived VO2 parameters 
may be outdated in our evolving patient population and 
subspecialised surgical care. Peak VO2 indexed to BSA may 
more accurately inform risk. The kinetics of VCO2 and HR 
combined with routine blood tests may further refine risk 
predictive models to assist in identifying at-risk patients and 
those with modifiable cardiorespiratory disease amenable to 
preoperative optimisation.
References: 1. Bolshinsky V, et al., Diseases of the Colon & 
Rectum, 61: 124-138, 2018. 2. Hansen JE, et al., Chest, 132: 
977-983, 2007
Time-driven activity based costing to model the utility of 
parallel induction room redesign in high turnover surgical 
lists
Dr Jarrod Basto (Peter MacCallum Cancer Centre, University 
of Melbourne, Melbourne, Victoria), Dr Rani Chahal (Peter 
MacCallum Cancer Centre, University of Melbourne), 
Professor Bernhard Riedel (Peter MacCallum Cancer Centre, 
University of Melbourne)
Introduction: Time-Driven Activity Based Costing (TDABC) 
is an important tool in quantifying complex costs within 
healthcare and has been used to project costs of altered staff 
ratios and workflow modifications prior to implementing 
process improvements [1]. Under a parallel induction design, 
additional personnel are used to optimise theatre efficiency 
by using an induction room to perform anaesthesia related 
procedures and induction in subsequent patients but prior 
to completing the preceding surgical case. In doing so, the 
non-operative time between cases is reduced and this may 
potentially improve case throughput [2]. As such, parallel 
induction exists in contrast to a traditional serial induction 
design where patients are induced in theatre sequentially 
by the same anaesthetic team. Within this context, we used 
TDABC to model personnel costs and time savings for a high 
turnover operating list of breast and melanoma procedures 
under a parallel induction design following an observational 
trial within theatre. 
Methods: We instituted an observational trial of serial and 
parallel workflow in theatre among 19 surgical lists (10 
parallel; 9 serial). Non-operative time was defined from 
the final closure of skin until the beginning of surgical 
preparation. Statistical analysis of non-operative time 
differences was performed by two-tailed t-tests comparing 
mean differences of log-transformed data. Using observed 
process times, we constructed a 6-case model of our all-
day operating list integrating non-operative time under 
either a serial or parallel induction design. Using TDABC we 
subsequently assigned personnel costs to these models based 
on differences in personnel input, including an additional 
20 minutes per turnover of anaesthetic nursing input. We 
also evaluated the mean revenue generated from analysed 
cases using the weighted inlier equivalent separation (WIES) 
of single day admissions to determine potential added value 
from scheduling an additional case. 
Results: Our observational trial in theatre demonstrated 
an 11-minute reduction in median non-operative time (p 
<0.0001) under a parallel induction design (24 minutes; IQR 
18-35) compared to a serial induction design (35 minutes, 
IQR 29-44). Modelling this improvement using TDABC, 
our high turnover list of 6 cases projected a reduced total 
operating list time of 9.8% (55 minutes) under a parallel 
induction design, at an increase of 1.8% to theatre-
designated personnel costs for the day. This redesign would 
allow for an additional typical short duration case, e.g. Wide 
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Local Excision, to be performed, with a return on investment 
averaging $2,818 and a projected time requirement of 58 
minutes (operative and non-operative time included).
Conclusions: A parallel induction design significantly reduced 
non-operative time within our trial in theatre. Projecting 
this improvement within our high turnover operating list 
demonstrated a 55-minute saving in total operating list time, 
expected to come at minimal increase in personnel costs as 
assessed by TDABC. An additional case short duration case, 
e.g. Wide Local Excision, is likely feasible under this model 
and represents value for our all-day, high turnover operating 
lists. 
References: 1. French KE, et al., Healthcare, 4: 173-180, 
2015. 2. Sandberg WS, et al., Anesthesiology, 103: 406-418, 
2005.
Costoclavicular vs paracoracoid approach to infraclavicular 
brachial plexus block: a randomized controlled trial
Dr Brigid Brown (Western University, London, Ontario, 
Canada), Dr Pauline Magsaysay (Western University), Dr 
Janice Yu (Western University), Dr Yves Bureau (Western 
University), Dr Shalini Dhir (Western University)
Background: Infraclavicular brachial plexus block is a regional 
anesthesia technique used for upper limb surgeries below 
the humerus. The traditional method of performing an 
infraclavicular block is using the paracoracoid approach(PC), 
in which the ultrasound transducer is placed near the 
coracoid process in the sagittal plane and the cords of the 
brachial plexus are visualized around the axillary artery. 
However, in this view, the cords are separated from one 
another, there is significant variation in the position of the 
individual cords relative to the axillary artery, and all 3 cords 
are rarely visualized in a single ultrasound window. Recently, a 
new approach to the infraclavicular block has been described 
in the literature, in which the ultrasound transducer is placed 
parallel to the clavicle and the block needle is inserted 
inplane from a lateral direction into the costoclavicular (CC) 
space. Anatomic studies have described how at this position, 
the cords are clustered together around the lateral edge of 
the artery at a more superficial level compared with the PC. 
The cords and needle may therefore be easier to visualize 
with less needle manipulation to perform the block. Potential 
benefits of this approach may include a faster onset of 
block and lower incidence of vascular puncture. When the 
patient’s arm is abducted, the plexus is moved further away 
from the pleura adding a level of safety. These studies all 
conclude that there is a need for more research into this 
approach evaluating safety and efficacy. We have undertaken 
a randomized controlled trial evaluating the feasibility of the 
CC infraclavicular block. 
Methods: After ethics approval was obtained, 70 adult 
patients undergoing ambulatory upper limb surgery 
were enrolled and randomized by a computer-program 
randomization to undergo either a paracoracoid or 
costoclavicular inflaclavicular block. Allocation concealment 
occurred using sealed opaque envelopes, which were opened 
after enrolment. Exclusion criteria included inability to give 
informed consent, allergy to local anesthetics, narcotic 
abuse, peripheral neuropathy, coagulopathy, BMI ≻35, and 
pregnancy or breastfeeding. Both groups received the same 
volume and concentration of 35 mL of 0.5% ropivacaine 
injected under ultrasound guidance with nerve stimulation. 
Primary outcome was block onset time and block success at 
30 minutes. Other secondary measured outcomes included 
performance times, complications during block insertion 
(paresthesia, vascular puncture, pleural puncture), patient 
satisfaction, and postoperative complications. Patients were 
followed up by phone call at postoperative days one and 
seven.
Results: Primary outcomes - Overall there was no statistically 
significant difference between sensory block onset time 
between groups. Similarly, block success at 30 minutes was 
the same between both groups, with similar conversion to 
general anesthetic and local anesthetic supplementation. 
Secondary outcomes - No significant difference in total 
procedure time – paracoracoid - 162 seconds, costoclavicular 
188 seconds. Complications during the block – no difference 
between the groups. Postoperative complications were also 
similar between the groups as was patient satisfaction scores 
at day 1 and day 7 postoperative.
Conclusion: In conclusion we have found in this non-
inferiority study that the novel costoclavicular approach of 
infraclavicular brachial plexus block resulted in similar block 
onset times, block success, and complication rates compared 
with the traditional paracoracoid approach.
Effect of adding clonidine to ropivacaine in transversus 
abdominis plane blocks: a randomized pharmacokinetic 
study
Dr Jennifer Crawford (Royal Prince Alfred Hospital, University 
of Sydney, Sydney, NSW), A/Prof John Loadsman (Royal Prince 
Alfred Hospital, University of Sydney), Mr Kenny Yang (Royal 
Prince Alfred Hospital, University of Sydney), Prof Peter Kam 
(Royal Prince Alfred Hospital, University of Sydney)
Introduction: Clonidine has been used successfully to 
prolong the duration of action of local anaesthetics in 
peripheral nerve blocks, but its mechanism of action in 
this setting remains unclear. Some previous studies have 
supported that clonidine acts via a pharmacodynamic 
mechanism (Kroin et al. 2004) but other studies suggest 
that clonidine exerts a vasoconstrictor effect (Kopacz & 
Bernards 2001) similar to adrenaline, limiting the washout of 
local anaesthetic from its site of deposition. Therefore, we 
measured plasma ropivacaine concentrations after patients 
received transversus abdominis plane (TAP) blocks with and 
without clonidine.
Methods: Eighty women undergoing laparoscopic 
gynaecological surgery were randomly assigned to receive 
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1 of 4 TAP block solutions: 3 mg/kg of 0.2% ropivacaine 
(control), ropivacaine with clonidine 2 mcg/kg (clonidine), 
ropivacaine with 1:400,000 adrenaline (adrenaline), or 
ropivacaine and a subcutaneous injection of clonidine 2 
mcg/kg (SC clonidine). Total venous plasma ropivacaine 
concentrations were measured up to six hours after the block 
using gas chromatograph mass spectrometry.
Results: There were no significant differences in plasma 
ropivacaine concentrations between the control group 
and the clonidine group at any time point in the study, nor 
were there differences in the mean maximum ropivacaine 
concentration (Cmax) or time to maximum concentration 
(Tmax). The SC clonidine group also did not differ from the 
controls. Plasma ropivacaine concentrations in the adrenaline 
group were significantly lower than the controls from 10 to 
90 minutes (p<0.003), and the Cmax was less than that of the 
control group (1.36 mcg/ml vs 1.99 mcg/ml, p<0.001) with a 
longer Tmax (103.5 min vs 51.0 min, p=0.001).
Conclusions: Clonidine at a concentration of 1.35 mcg/
ml added to ropivacaine in TAP blocks did not produce 
vasoconstriction as evidenced by a lack of reduction in 
plasma ropivacaine concentrations, lack of reduction 
in Cmax, and lack of prolongation of Tmax. Adrenaline, 
however, did cause vasoconstriction, consistent with previous 
studies. The 2 mcg/kg dose of clonidine used in this study 
was based on other previous studies but because 0.2% 
ropivacaine and high volume TAP blocks were used in this 
study, the final clonidine concentration may have been too 
low to cause vasoconstriction. Previous studies that have 
demonstrated a vasoconstrictor effect of clonidine have used 
clonidine concentrations of 10 mcg/ml or greater (Kopacz 
& Bernards 2001). Further studies should evaluate whether 
a vasoconstrictor effect is present when clonidine is used 
at higher concentrations and investigate the role of other 
possible pharmacodynamic mechanisms of action.
References: Kopacz, D.J. & Bernards, C.M., 2001. Effect 
of clonidine on lidocaine clearance in vivo: a microdialysis 
study in humans. Anesthesiology, 95(6), pp.1371–1376. 
Kroin, J.S. et al., 2004. Clonidine prolongation of lidocaine 
analgesia after sciatic nerve block in rats Is mediated via the 
hyperpolarization-activated cation current, not by alpha-
adrenoreceptors. Anesthesiology, 101(2), pp.488–494.
Sevoflurane in the penthrox inhaler
Dr Timothy Makar (Austin Hospital, Melbourne, Victoria), 
Dr Ned Douglas, Professor Philip Peyton (Austin Hospital, 
Melbourne University)
Introduction: The Penthrox inhaler was designed to deliver 
Methoxyflurane for analgesia and procedural sedation in 
ambulance and military settings1. Its performance has only 
been assessed for Methoxyflurane, which has not been used 
as an anaesthetic for many years in mainstream anaesthesia. 
Sevoflurane has many advantages over methoxyflurane for 
procedural sedation. First principles calculations suggest 
the Penthrox inhaler should deliver useful concentrations of 
sevoflurane for this purpose. The study aimed to evaluate the 
performance of the Penthrox inhaler delivering sevoflurane, 
as a precursor to clinical trials. 
Methods: An apparatus to simulate spontaneous ventilation 
was established. A Penthrox inhaler was filled with 
sevoflurane liquid and connected to the apparatus. A gas 
analyser (Datex Corp) sampled concentrations of sevoflurane. 
Two tidal volumes were tested (500ml and 1000ml), and 
other variables explored were occlusion of the dilutor hole 
on the inhaler and hand-warming the inhaler during delivery 
and the volume of sevoflurane initially instilled into the 
inhaler. The baseline trial involved a ventilation pattern of 
1000ml x 14bpm, dilutor hole covered, unwarmed and 6mls 
of sevoflurane. Comparisons were made with all of the non-
test variables held at these settings. Gas concentrations were 
recorded and displayed graphically. The difference between 
peak and plateau inspired concentrations and the time until 
depletion to an inspired concentration less than 0.2% were 
compared descriptively. 
Results: The pattern of inspired sevoflurane concentration 
was predictable, with an initial high peak, plateau phase and 
then a linear decline until exhaustion. A a closed dilutor hole 
delivered a higher plateau sevoflurane concentration than 
open (1.6% vs 0.6%) but depleted the inhaler faster (6min 
vs 13min). Warming the inhaler resulted in higher plateau 
sevoflurane concentrations (2.1% vs 1.6%) but the inhaler 
was depleted faster (5min vs 6min). A ventilation pattern of 
500ml x 14bpm compared to 1000ml x 14bpm resulted in 
a higher plateau sevoflurane concentration (2.0% vs 1.6%) 
and slower depletion from the inhaler (12min vs 6min). An 
instillation volume of 12mls compared to 6mls of sevoflurane 
lead to higher peak concentrations (3.1% vs 2.2%), higher 
plateau concentrations (1.8% vs 1.6%) and a longer time to 
depletion from the inhaler (10min vs 6min).
Conclusions: The Penthrox inhaler delivers clinically useful 
concentrations of sevoflurane in a bench model in most trials. 
The delivery profile follows a predictable pattern of high and 
rapidly declining concentration, followed by a plateau at a 
clinically useful concentration, followed by a linear decline 
to zero. The duration of useful plateau delivery is variable 
according to the volume of agent instilled in the agent and 
can be customised to the expected duration of procedure. 
Further clinical trials are required to investigate if this 
apparatus can produce reliable anaesthesia or sedation in 
humans, before consideration of clinical use. 
References: 1. Dayan AD. Analgesic use of inhaled 
methoxyflurane. Hum Exp Toxicol. 2015 Feb 19;35(1):91–100
Skin-to-epidural space distance in pregnancy: stronger 
association with body mass index than abdominal 
subcutaneous fat thickness
A/Prof Victoria Eley (The Royal Brisbane and Women’s 
Hospital, The University of Queensland, Brisbane, 
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Queensland), Dr Adrian Chin (The Royal Brisbane and 
Women’s Hospital, The University of Queensland), Dr 
Renuka Sekar (The Royal Brisbane and Women’s Hospital, 
The University of Queensland), A/Prof Tim Donovan (The 
Royal Brisbane and Women’s Hospital, The University of 
Queensland), Dr Amy Krepska (The Royal Brisbane and 
Women’s Hospital, The University of Queensland), Dr 
Sheridan Bell (The Royal Brisbane and Women’s Hospital, 
The University of Queensland), Dr Mitchell Lawrence (The 
Royal Brisbane and Women’s Hospital, The University of 
Queensland), Dr Shaun McGrath (The Royal Brisbane and 
Women’s Hospital, The University of Queensland), Mr Lachlan 
Webb (Queensland Institute of Medical Research Berghofer), 
Dr Alex Robinson (The Royal Brisbane and Women’s Hospital, 
The University of Queensland)
Introduction: Body mass index (BMI) is used to classify 
obesity but does not account for the distribution of adipose 
tissue. Measurement of abdominal subcutaneous fat 
thickness (SCFT) by ultrasound scan (USS) is a surrogate 
measure for central obesity1 and predicts adverse pregnancy 
outcomes.2 This study determined if the abdominal SCFT 
measured at the routine 18-22 week USS was correlated with 
skin-to-epidural space distance during labour epidural or 
caesarean section (CS) and compared this with BMI.
Methods: We analysed a sub-set of participants from a 
single-centre, prospective cohort study that assessed the 
relationship between SCFT and maternity outcomes at a 
tertiary hospital with approximately 4200 annual deliveries 
(HREC/14/QRBW/492). An opt-out approach was used. We 
identified those who had received an epidural (for labour 
analgesia) or combined spinal-epidural (for CS) and obtained 
demographic information, mode of delivery and skin-to-
epidural space distance from the electronic patient record. 
This was a sample of convenience, including only singleton 
pregnancies. Standard cervix-placenta images were obtained 
during the routine 18-22 week USS. Three abdominal SCFT 
measurements were subsequently obtained by one trained 
operator and the average calculated. Pearson’s correlation 
coefficient was calculated to describe the relationship 
between SCFT and skin-to-epidural space distance. This was 
repeated for the booking BMI and skin-to-epidural space 
distance, to determine which relationship was stronger. 
Linear regression was used to test for strength of association 
and adjusted R2 values calculated to determine if skin-to-
epidural space distance was more strongly correlated with 
SCFT or BMI. 
Results: Data was obtained for 493 women delivering 
between February 2015 and June 2016 (46% of the total 
sample of 1071). The mean (SD) age was 30.5 (5.5) years; 
241 (48.9%) were nulliparous, 348 (70.6%) Caucasian and 
458 (92.9%) delivered at a gestation >37 weeks. The mode 
of delivery was as follows: vaginal delivery 242 (49.1%), 
emergency CS 137 (27.8%), elective CS 114 (23.1%). The 
median (IQR) booking weight was 67.5 (60.0-80.0) kg and 
BMI was 25.0 (21.9-29.2) kg/m2; 107 (21.7%) had a BMI 
≥ 30 kg/m2 and the BMI range was 17.3-56.7 kg/m2. The 
median (IQR) SCFT was 16.2 (13.0-20.9) mm, range 7.0-73.4 
mm. The median (IQR) skin-to-epidural space distance was
5.0 (4.5-6.0) cm, range 3.0-10.0 cm. There was a significant
correlation between SCFT and skin-to-epidural space
distance, r=0.526, p<0.001 and also between BMI and skin-
to-epidural space distance, r=0.682, p<0.001. The adjusted
R2 value (adjusted for age, parity, premature delivery, mode
of delivery) for SCFT was 0.280 and for BMI was 0.464.
Conclusions: This novel study demonstrated a moderately
strong correlation between both SCFT and BMI, with skin-
to-epidural space distance. BMI showed the stronger
association, explaining 46% of the variability in skin-to-
epidural space distance. This study will inform further work
on the relationship between SCFT, BMI and locating the
epidural space.
References: 1. Fox CS, Massaro JM, Hoffmann U, et al.
Abdominal Visceral and Subcutaneous Adipose Tissue
Compartments: Association With Metabolic Risk Factors in
the Framingham Heart Study. Circulation 2007;116:39-48.
2. Kennedy NJ, Peek MJ, Quinton AE, et al. Maternal
abdominal subcutaneous fat thickness as a predictor for
adverse pregnancy outcome: a longitudinal cohort study.
BJOG 2016;123:225-32.
Pre-operative neurocognitive impairment and delirium in
the post-anaesthesia care unit: an observational study
Dr Amy Gaskell (Waikato Hospital, University of Auckland,
Auckland, New Zealand), Ms Ashleigh Brough (University of
Auckland), Ms Abbe Meads (University of Auckland), Prof
Jamie Sleigh (Waikato Hospital, University of Auckland)
Introduction: With the aging population, increasing numbers
of patients with neurocognitive impairment will undergo
anaesthesia and surgery; these patients are at higher risk
of experiencing postoperative delirium. Current guidelines
for the prevention of postoperative delirium advise routine
preoperative cognitive screening to identify patients at high
risk[1]. Delirium in the post-anaesthesia care unit (PACU) has
been linked to further episodes of postoperative delirium
and other adverse outcomes[2], however the optimal
method of measuring early neurocognitive recovery following
anaesthesia is not clear. The 3-Minute Diagnostic Assessment
for Delirium using the Confusion Assessment Method
(3D-CAM) is a tool validated for the diagnosis of delirium,
however it has not been reported in the PACU setting. Our
aims were to determine the baseline cognitive status of our
surgical population, estimate the incidence of PACU delirium,
and to appraise the feasibility of preoperative cognitive
screening and 3D-CAM testing in PACU as research tools.
This is a pilot study in preparation for a planned randomised
controlled trial of two intraoperative strategies to improve
early neurocognitive recovery following anaesthesia in older
patients.
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Methods: We recruited patients aged 60 years and older 
undergoing elective surgery at Waikato Hospital. The study 
had ethics and local authority approvals and informed 
consent was obtained from participants. The Montreal 
Cognitive Assessment (MOCA) was performed preoperatively 
and 3D-CAM assessments were performed in the post-
anaesthesia care unit. Logistic regression was performed to 
test the association between preoperative MOCA scores and 
performance in the 3D-CAM in PACU.
Results: 112 participants underwent preoperative cognitive 
evaluation. The median (IQR) MOCA score was 24 (22-26); 
79 (71%) participants scored below the normal range (MOCA 
score over 26) and 11 (10%) participants had a score of 17 
or lower. The MOCA took a median time (IQR) of 12 (10-15) 
minutes to complete. Of the 89 participants who underwent 
3D-CAM evaluations in PACU, 39 (43%) met 3D-CAM criteria 
for delirium and 74 (83%) had evidence of inattention. 
3D-CAM testing took a median (IQR) of 3 (2-4) minutes. 
Preoperative MOCA scores were associated with post-
operative delirium (unadjusted OR 0.88[0.79-0.99] per MOCA 
point, p=0.028).
Conclusion: Mild-moderate neurocognitive impairment 
is common in older patients undergoing surgery and is 
associated with PACU delirium. The 3D-CAM appears to be a 
feasible tool for use in the post-anaesthesia care unit. 
References: 1. Aldecoa C, Bettelli G, Bilotta F, et al. European 
Society of Anaesthesiology evidence-based and consensus-
based guideline on postoperative delirium. European journal 
of anaesthesiology 2017;34(4):192-214. 2. Hernandez 
BA, Lindroth H, Rowley P, et al. Post-anaesthesia care unit 
delirium: incidence, risk factors and associated adverse 
outcomes. British journal of anaesthesia 2017;119(2):288-90.
Simulation to assess latent safety threats and operational 
preparedness within anaesthetic locations in a new 
children’s hospital
Dr Nathalie Gomes (Monash Health, Monash Simulation, 
Melbourne, Victoria), Dr Noel Roberts (Monash Health, 
Monash Simulation)
Introduction: Prior to the opening of Monash Children’s 
Hospital, the Monash Anaesthesia, Simulation and Paediatric 
Surgical Departments planned and implemented in-situ 
simulations to detect and rectify latent safety threats (LSTs) 
and assess operational preparedness of anaesthetic and 
associated departments. LSTs have been defined as system-
based threats to patient safety that can materialize at any 
time and are previously unrecognized1. The simulations also 
provided an opportunity for staff to become more familiar 
with the new environment, and to practice procedural 
guidelines within an interprofessional team. Simulation has 
been shown to play a meaningful role in systems testing and 
staff orientation to new departments2.
Methods: Scenarios appropriate for interprofessional 
involvement were designed around routine cases, patient 
transfers, and management of crises. Clinical environments 
included operating theatres, NICU, Diagnostic Imaging (DI), 
and the Children’s Cancer Centre (CCC).
Participants were employees from nursing, medicine 
and administration, who were soon to work in the new 
facility. Prebriefing sessions included orientation to the 
environment and simulation equipment. Following each 
scenario, formal debriefing took place guided by experienced 
facilitators. Discussion involved analysis of and reflection on 
performance. Systematic identification of any systems issues 
together with suggested solutions was then sought. After 
the session, participants were asked to complete an online 
questionnaire to specify any other potential improvements, 
and to explore reflection and feelings of improved workforce 
preparedness. The primary outcome measure was the 
number and type of LSTs identified. The secondary outcome 
measures were the participants’ assessment of the impact of 
simulation on workforce preparedness and the likelihood of 
communication of issues of concern in the future.
Results: Fourteen simulations were implemented over 4 
days and over 50 LSTs were identified. Those of high priority 
included the failure of two line isolation systems to come 
back online after a system test shut down, inadequate 
emergency alarm volumes in each theatre, delays in 
accessing certain life-saving medications (eg Intralipid) 
due to storage site location, and equipment, staffing and 
ergonomic issues in NICU, DI and CCC. For each high 
priority issue identified, relevant leadership reviewed the 
proposed solutions and implemented changes. All high 
priority LSTs were addressed before opening the facility. 
60% of participants responded to the online questionnaire. 
All respondents either agreed or strongly agreed that 
their participation in the simulations improved workforce 
preparedness. In addition, more than 80% agreed or strongly 
agreed that they were more likely to communicate issues of 
concern in the future as a result of the simulation testing.
Conclusions: In-situ simulation is an effective and practical 
means of identifying LSTs and operational preparedness in 
operating theatres and off-the-floor anaesthetic locations 
within new facilities. In addition, it may increase the 
likelihood that issues of concern are raised by staff once the 
facility is open. 
References: Alfredsdottir H, Bjornsdottir K. Nursing 
and patient safety in the operating room. J Adv Nurs. 
2008;61(1):29-37. Adler MD et al. Use of simulation to test 
systems and prepare staff for a new hospital transition. J 
Patient Saf. 2015;00:00.
A pilot study on the perioperative ROTEM changes across 
obesity categories during lower limb joint replacements
Dr Usha Gurunathan (The Prince Charles Hospital and 
University of Queensland, Brisbane, Queensland), Dr Lisa  
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Stanton (The Prince Charles Hospital), Dr Rachael Weir (The 
Prince Charles Hospital), Dr  Karen Hay (QIMR), Dr Scott 
Mckenzie (The Prince Charles Hospital), Mrs Brownyn Pearse 
(The Prince Charles Hospital)
Introduction: Major orthopaedic joint surgery such 
as total hip and knee replacements may contribute to 
hypercoagulability in all patients. Obese patients undergoing 
joint replacements are reportedly at higher risk of thrombotic 
complications than non-obese because of their increased 
clotting tendencies and aspirin resistance (1). Coagulation 
changes during major joint replacements have been 
examined using conventional clotting tests, but most of these 
studies have been old and cannot be fully accepted with 
surgical practice changes (2). Furthermore, these studies 
have only looked at selective thrombotic or fibrinolytic 
markers and their utility detecting hypercoagulability is 
questionable. Functional viscoelastic point of care test such 
as ROTEM (rotational thromboelastometry) provides a timely, 
comprehensive assessment of overall clotting pathway. There 
is limited information about the coagulation changes during 
joint replacements using the rotational thromboelastometry 
(ROTEM) assays. This necessitates a preliminary study on 
the coagulation changes in patients undergoing lower 
limb joint replacements and the influence of obesity on 
those changes. Methods: Eligible patients undergoing THR 
and TKR were recruited for this study. Their demographic, 
medical, treatment history and laboratory test results were 
collected. There were no changes in surgical or anaesthetic 
management. Data on intraoperative factors including type of 
surgery, duration of surgery, type of anaesthesia, tranexamic 
acid, transfusion, intraoperative complications were recorded. 
These patients were followed up until discharge. Venous 
blood samples were taken ROTEM and Multiplate analysis at 
four time points, namely, beginning and end of surgery, day 1 
and day 3 following surgery. Three different kinds of ROTEM 
assays: INTEM, EXTEM and FIBTEM were performed. 
Results: Forty seven patients (M=20, F=27) were recruited 
for this pilot study. The mean age was 67 +/- 9 years (range: 
45-81). Mean BMI: 34 kg/m2(SD:8), waist circumference: 110 
cm (SD: 18); Hip circumference: 115 cm (SD: 16), waist to hip 
ratio: 0.96; Neck circumference: 41 cm (SD: 5). Significant 
changes (p<0.01) were observed with time; with EXTEM 
decrease in CFT, increase in alpha angle & MCF, with INTEM: 
Decrease in CFT, A10 & MCF, and with FIBTEM: Increase in 
A10, MCF & alpha angle. With an increasing BMI, both with 
EXTEM and INTEM, CFT decreased and MCF &A10 increased. 
On average MCF increased 0.18 units for each additional unit 
of BMI. These results were significant at the 5% level. 
Conclusion: There was some evidence that ROTEM 
parameters varied with BMI across the perioperative period. 
Specifically, both with EXTEM and INTEM, compared to 
baseline preoperative values, CFT decreased and MCF &A10 
increased with increasing BMI. Some of these changes have 
been linked to adverse outcomes such as postoperative 
thromboembolic complications in the literature. 
Reference: 1. Campello E, Zabeo E, Radu CM, et al. 
Hypercoagulability in overweight and obese subjects who 
are asymptomatic for thrombotic events. Thromb Haemost. 
Jan 8 2015;113(1):85-96. 2. Thorson CM, Van Haren RM, 
Ryan ML, et al. Persistence of hypercoagulable state after 
resection of intra-abdominal malignancies. J Am Coll Surg. 
Apr 2013;216(4):580-589; discussion 589-590.
Transnasal sphenopalatine ganglion block for post dural 
puncture headache – results of a local case series
Dr Nathan Hewitt (St George Hospital, Sydney, NSW), Dr 
Andrea Jeyendra (St George Hospital), Dr Izreen Mohamed 
Iqbal (St George Hospital), Dr Leonard Kalish (The Sutherland 
Hospital, Sydney, NSW)
Introduction: Transnasal sphenopalatine ganglion block 
(SPGB) has been described as a minimally invasive treatment 
option for post dural puncture headache (PDPH)1. It may 
be safer and as efficacious as the gold standard epidural 
blood patch (EBP)1,2. We report a case series of 16 patients 
receiving SPGB to manage PDPH at two sites within the South 
Eastern Sydney Local Health District.
Methods: A transnasal SPGB was performed in 16 
consecutive patients as first line management of a confirmed 
symptomatic PDPH between June 2016 and December 2017. 
The SPGB was performed in patients positioned supine with 
a slight head down tilt. Co-phenylcaine forte spray was used 
to topicalise both nasal passages, before cotton tips coated in 
2% viscous lignocaine were inserted along the nasal floor, to 
the nasopharynx bilaterally. Additional 0.5mL aliquots of 0.5% 
bupivacaine with adrenaline 1:200,000 were applied to the 
cotton tip at 5 minute intervals over 20 minutes (total 4mL). 
The primary outcomes assessed were pain scores (using the 
numerical rating scale (NRS)) and opioid requirements pre-
and post intervention. Secondary outcomes assessed were 
time to mobilisation, need for further intervention (EBP or 
repeat SPGB) and time to hospital discharge.
Results: There were 18 SPGBs performed on 16 patients 
(95% female). PDPH following epidural analgesia in obstetrics 
accounted for 9/16 (56%), while the remaining 7/16 cases 
occurred post diagnostic lumbar puncture (LP). Lower 
pain scores were reported in 83% of patients immediately 
post SPGB (NRS 5.9 pre- vs. 2.4 post-SPGB; p=0.005), with 
complete resolution of pain in 39%. However, there was no 
reduction in pain score at 24 hours (NRS 5.9 vs. 4.4; p=0.30). 
There was no difference in the opioid requirement in the 
24 hours pre- or post-SPGB (oral morphine equivalent 11mg 
vs. 13mg; p=0.26). The average time to mobilisation and 
hospital discharge was 11 and 36 hours, respectively. One 
obstetric patient received a primary SPGB two days following 
a failed EBP with good effect. Five patients required further 
intervention following SPGB. Two patients received a second 
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SPGB, which successfully treated the pain in one. In total, 4/9 
obstetric patients (44%) required an EBP for failed SPGB. No 
patient treated with a SPGB following a LP required further 
intervention.
Conclusions: SPGB may provide symptomatic relief in mild to 
moderate PDPH. It may be a useful adjuvant allowing early 
symptom control and the optimisation of oral analgesia, 
or sole therapy in mild cases. All non-obstetric, and 56% 
of obstetric patients were discharged without requiring 
an EBP. The SPGB is minimally invasive, easily repeatable 
and provides promising results in the observed cohort. A 
dedicated prospective multi centre RCT examining its efficacy 
is warranted. 
References: 1.Cohen S, Ramos D, Grubb W, Mellender S, 
Mohiuddin A, Chiricolo A. Sphenopalatine ganglion block: 
A safer alternative to epidural blood patch for postdural 
puncture headache. Reg Anesth Pain Med 2014;39:563. 
2.Patel P, Cohen S, Zhao R, Mellender S, Shah S, Grubb W. 
Sphenopalatine ganglion block (SPGB) vs epidural blood 
patch (EBP) for accidental post dural puncture headache 
(PDPH) in obstetric patients  – a retrospective observation. 
The American Academy of Pain Medicine Annual Meeting. 
California, 2016.
Anaesthesia record keeping in an Australian metropolitan 
tertiary public teaching hospital
Dr Victor Hui (Austin Health, Melbourne, Victoria), Dr Fiona 
Desmond (Austin Health)
Introduction: The anaesthetic record is the only anaesthetic 
related record that documents the patient’s perioperative 
journey. The Australian and New Zealand College of 
Anaesthetists (ANZCA) has published a professional 
document detailing what should be recorded in an episode 
of anaesthetic care1. The aim of this project is to determine 
documentation compliance to college recommendations in 
an Australian tertiary hospital.
Methods: Austin Health is a metropolitan tertiary public 
teaching hospital in Melbourne, Australia; it provides 980 
beds across three campuses. Patients having surgery at 
Austin Health over a 7 day period were included in this 
audit. Exclusions include: gastroscopy, colonoscopy, flexible 
cystoscopies, local anaesthetic only procedures without 
sedation, chronic pain procedures and if the patient’s 
medical records were not electronically available. Austin 
Health’s anaesthetic records are paper based and require 
the anaesthetist to manually record all data. The patient’s 
anaesthetic records were retrospectively analysed. The 
primary outcome was the incidence of inadequately 
documented anaesthetic records according to the ANZCA 
recommendations. This project received ethical approval 
from the Austin Health Human Research Ethics Committee 
prior to data collection.
Results: During the period of 20th to 26th March 2017 
inclusive, 588 patients underwent a procedure and 381 
were included for this project. Overall, 17% (64/381) of the 
included charts followed all of the ANZCA recommended 
guidelines. Specific inadequately documented areas of the 
anaesthetic record and its incidence of completion include: 
name of procedure (95%), date of procedure (84%), name of 
surgeon (43%), ASA score (80%), allergies (98%), anaesthetic 
consent (80%), name or signature of anaesthetist (90%), eye 
protection (72%) and airway device (92%).
Conclusions: Overall, the number of charts compliant in all 
ANZCA recommendations was poor. Particularly important 
areas that were not completed include: planned or actual 
procedure, name or signature of anaesthetist, consent, 
airway assessment and airway device. Lack of adequate 
documentation in these areas could lead to patient morbidity 
and medico-legal issues; the completion rate should be 
100%. This project should raise awareness for all hospital 
staff that anaesthetic documentation is important and can be 
improved on.
References: 1. Australian and New Zealand College of 
Anaesthetists. The Anaesthesia Record. Recommendations 
on the Recording of an Episode of Anaesthesia Care. 
PS06. Revised 2006. Accessed from: http://www.anzca.
edu.au/documents/ps06-2006-the-anaesthesia-record-
recommendations-o.pdf (last accessed 25/07/17)
Post-operative outcomes among patients undergoing 
elective hip and knee joint replacements – impact of  
pre-operative anaemia
Dr Dinushka Kariyawasam (Canberra Hospital, ACT Health, 
Canberra, ACT), Miss Dannielle Duong (Western Sydney 
University, Sydney, NSW), Dr Sharavni Gupta (Blacktown and 
Mount Druitt Hospital, Sydney, NSW), Dr Viraj Kariyawasam 
(Blacktown and Mount Druitt Hospital )
Introduction: Pre-operative anaemia is associated 
with adverse outcomes among patients undergoing 
elective surgery. These include increased length of stay, 
post-operative infections and mortality. Older age and 
co-morbidities have also been implicated with poor outcomes 
post-surgery. More than 50% of anaemic patients were found 
to be iron deficient. 
Aim: To assess the rate of pre-operative anaemia and 
it’s impact on post-operative outcomes among patients 
undergoing elective hip and knee replacement surgeries. 
Methodology: Patients who underwent elective hip and 
knee surgery at Blacktown and Mount Druitt hospitals 
between 1st July 2015 to 30th June 2016 were included. 
Anaemia was classified according to WHO criteria. Patient 
demographics, co-morbidities, anthropometry, pre, intra 
and post-operative parameters were collected. Continuous 
variables are presented as medians and ranges. Categorical 
variables are presented as percentages. Kruskal-Wallis and 
chi square non-parametric analyses were performed. Binary 
logistic regression analysis was performed to identify factors 
associated with complications. 
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Results: A total of 472 patients underwent elective Hip 
and Knee replacement surgeries during the study period. 
10 patients were excluded due to lack of preoperative 
haemoglobin. Prevalence of anaemia was 19.7% (n=91). Mild 
anaemia was found in 75 patients, while 16 had moderate 
anaemia. Only 14 patients with anaemia had ferritin level 
performed. Patients with anaemia were older and had a 
higher comorbidity index. Mean length of stay among all 
patients was 7.1 days (SD 5.5). Patients with anaemia had a 
significantly higher length of stay compared to non-anaemic 
patients (8.64 vs 6.73, p=0.003). They were likely to be 
readmitted within 30-days post discharge (12.1% vs 5.4%, 
p=0.016). They also required higher blood transfusions 
compared to non-anaemic patients (14.35 vs 2.7%, 
p<0.0001). A total of 140 (30.3%) patients had complications 
post-surgery. Infective (18.0%), renal impairment (8.2%) and 
cardiovascular (5.6%) complications were the commonest 
reported. Anaemia was associated with higher rate of overall 
complications (p<0.0001), renal impairment (p<0.0001) and 
infective complications (p=0.005). Anaemia was found to be 
an independent predictor of any complication (Odds ratio 
(OR) 2.20, 95% confidence interval (CI) 1.26-3.86, p=0.006), 
renal impairment (OR 3.65, 95%C 1.77-7.54, p<0.0001) and 
infective complications (OR 1.88, 95%CI 1.03-3.41, p=0.038) 
on multivariate regression analysis. 
Conclusion: Among patients undergoing elective hip and 
knee surgery, anaemia was associated with increased length 
of stay, 30 day readmission rates, increased blood transfusion 
rates and complications. Infective and renal complications 
were significantly higher among patients who were anaemic 
pre-operatively. Assessment of anaemia is poorly performed. 
Correcting anaemia may present an opportunity to improve 
the surgical outcomes in post elective hip and knee 
replacements.
Rotational thromboelastometry (ROTEM®) in obstetrics: 
baseline parameters in uncomplicated and complicated 
pregnancies. A prospective observational study on elective 
Caesarean section patients
Dr Julie Lee (The Royal Brisbane and Women’s Hospital, The 
University of Queensland, Brisbane, Queensland), A/Prof 
Victoria Eley (The Royal Brisbane and Women’s Hospital, 
The University of Queensland), A/Prof  Kerstin Wyssusek 
(The Royal Brisbane and Women’s Hospital, The University 
of Queensland), A/Prof Jeremy Cohen (The Royal Brisbane 
and Women’s Hospital, The University of Queensland), Dr 
John Rowell (The Royal Brisbane and Women’s Hospital, The 
University of Queensland), Ms Mandy Way (QIMR Berghofer 
Medical Research Institute), Professor Andre Van Zundert 
(The Royal Brisbane and Women’s Hospital, The University Of 
Queensland)
Introduction: Rotational thromboelastometry (ROTEM®) is a 
point-of-care test of coagulation. The use of ROTEM® is well 
established in hepatic and cardiac surgery, but not as yet 
in the obstetric setting1,2. Formal baseline parameters are 
yet to be established in normal pregnancy. This prospective 
observational study aimed to establish baseline parameters 
in an Australian obstetric population undergoing elective 
Caesarean sections (CS). 
Methods: Ethics approval and written informed consent were 
obtained. Women undergoing an elective CS were recruited 
at a tertiary referral hospital during a 12-month period in 
2016. The sample included women with uncomplicated 
and complicated pregnancies. Patients were considered 
“uncomplicated” if obstetrically and medically low risk, 
whilst patients were considered “complicated” if they had 
pre-existing co-morbidities including obesity, pregnancy-
related conditions, or on medications affecting coagulation. 
Patients were recruited from the maternity preadmission 
clinic if they were booked for an elective CS at greater 
than 30 weeks’ gestation. ROTEM® sampling occurred on 
insertion of an intravenous cannula pre-operatively. ROTEM® 
reference ranges were derived by calculating the 2.5 and 
97.5 percentiles for INTEM/EXTEM/FIBTEM amplitude at 5 
minutes (A5), amplitude at 15 minutes (A15), coagulation 
time (CT), maximum clot firmness (MCF) and clot formation 
time (CFT).
Results: Of the 200 women recruited, 132 (59%) were 
uncomplicated and 68 (34%) were complicated pregnancies, 
with a mean age of 32.7 years (SD 5.0), median gestation 
of 39 weeks (IQR 38.3-39.3) and median BMI of 25.6 kg/
m2 (IQR 22.0-29.7), of which 23 (11.5%) had a postpartum 
haemorrhage (PPH) with a median volume of 450 mL (IQR 
300-600) blood loss. Forty-six (23%) women were nulliparous
and 132 (66%) were presenting for a repeat CS. ROTEM®
reference ranges were derived based on results from 132
patients in the uncomplicated group. The median and
interquartile range (IQR) for selected ROTEM® parameters
are as follows: FIBTEM A5 20 mm (IQR 17-22), FIBTEM A15
23 mm (20-25), FIBTEM CT 53 s (50-57), FIBTEM MCF 24 (20-
27), FIBTEM CFT 265 (160-628), EXTEM A5 53 mm (50-57),
EXTEM A15 67 mm (65-70), EXTEM CT 54 seconds (s) (49-57),
EXTEM MCF 70 mm (68-73), EXTEM CFT 64 s (57-72), INTEM
A5 51 mm (48-55), INTEM A15 66 mm (63-68), INTEM CT 165
s (145-186), INTEM MCF 69 mm (66-71), and INTEM CFT 63
s (54-72).
Conclusion: We have provided reference ranges for ROTEM®
values in women with uncomplicated pregnancies presenting
for an elective Caesarean section. As expected, these ranges
show an increase in coagulability during normal pregnancy
compared to the non-pregnant population.
References: 1. King K, Setty S, Thompson K, McGlennan
A and Wright A. Rotational thromboelastometry (ROTEM)
- the future of point of care testing in obstetrics? Archives
of Disease in Childhood - Fetal and Neonatal Edition. 2011;
96: 120-1. 2. Wegner J and Popovsky MA. Clinical utility of
thromboelastography: one size does not fit all. Seminars in
thrombosis and hemostasis. 2010; 36: 699-706.
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Rotational thromboelastometry (ROTEM®) in obstetrics: 
baseline parameters in uncomplicated and complicated 
pregnancies. A prospective observational study on 
parturients
Dr Julie Lee (The Royal Brisbane and Women’s Hospital, The 
University of Queensland, Brisbane, Queensland), A/Prof 
Victoria Eley (The Royal Brisbane and Women’s Hospital, 
The University of Queensland), A/Prof Kerstin Wyssusek 
(The Royal Brisbane and Women’s Hospital, The University 
of Queensland), A/Prof Jeremy Cohen (The Royal Brisbane 
and Women’s Hospital, The University of Queensland), Dr 
John Rowell (The Royal Brisbane and Women’s Hospital, 
The University of Queensland), A/Prof Rebecca Kimble (The 
Royal Brisbane and Women’s Hospital, The University of 
Queensland), Ms Mandy Way (QIMR Berghofer Medical 
Research Institute), Professor Andre Van Zundert (The 
Royal Brisbane and Women’s Hospital, The University of 
Queensland)
Introduction: Rotational thromboelastometry (ROTEM®) is a 
point-of-care test that provides rapid and specific coagulation 
assessment. The use of ROTEM® is well established in hepatic 
and cardiac surgery, but not as yet in the obstetric setting1,2. 
This prospective observational study aimed to establish 
baseline parameters in an Australian parturient population. 
Methods: The study population was recruited at a tertiary 
hospital via an opt-out approach approved by the local 
ethics committee. Patients were included in the study upon 
presentation to the labour ward at the point of requiring 
intravenous cannulation or venepuncture. The sample 
included women with uncomplicated and complicated 
pregnancies. Patients were considered “uncomplicated” 
if obstetrically and medically low risk, whilst patients 
were considered “complicated” if they had pre-existing 
co-morbidities including obesity, pregnancy-related 
conditions, or on medications affecting coagulation. Patients 
aged 18 to 55 years inclusive and at greater than 30 weeks’ 
gestation who presented to the obstetric unit in established 
labour were included. There was no exclusion based on 
co-morbidities. ROTEM® reference ranges were determined 
by calculating the 2.5 and 97.5 percentiles for the 
uncomplicated group for INTEM/EXTEM/FIBTEM amplitude at 
5 minutes (A5), amplitude at 15 minutes (A15), coagulation 
time (CT), maximum clot firmness (MCF) and clot formation 
time (CFT).
Results: Of 174 women, 107 (61.5%) were uncomplicated, 
with a mean age of 29.3 years (SD 5.4), median gestation of 
39 weeks (IQR 37.1-40.3) and median BMI of 24.3 kg/m2 (IQR 
21.7-30.4), of which 102 (58.6%) were delivered vaginally 
with the remainder proceeding to a CS. 104 (59.8%) women 
were nulliparous. Postpartum haemorrhage (PPH) was seen 
in 37 (21.3%) parturients with a median blood loss of 400 
mL (IQR 250-700). The median and interquartile range (IQR) 
for selected ROTEM® parameters of uncomplicated women 
were as follows: FIBTEM A5 21 mm (IQR 18-24), FIBTEM A15 
25 mm (21-27), FIBTEM CT 50 s (48-54), FIBTEM MCF 26 (22-
29), FIBTEM CFT 188 (109-391), EXTEM A5 55 mm (52-58), 
EXTEM A15 69 mm (66-71), EXTEM CT 52 seconds (s) (48-56), 
EXTEM MCF 72 mm (69-73), EXTEM CFT 59 s (53-70), INTEM 
A5 53 mm (50-56), INTEM A15 67 mm (64-69), INTEM CT 164 
s (144-182), INTEM MCF 70 mm (68-71), and INTEM CFT 59 
s (52-67).
Conclusion: We have provided reference ranges for ROTEM® 
in labouring pregnant women. As expected, these ranges 
show an increase in coagulability during normal pregnancy 
compared to the non-pregnant population.
References: 1. King K, Setty S, Thompson K, McGlennan 
A and Wright A. Rotational thromboelastometry (ROTEM) 
- the future of point of care testing in obstetrics? Archives
of Disease in Childhood - Fetal and Neonatal Edition. 2011;
96: 120-1. 2. Wegner J and Popovsky MA. Clinical utility of
thromboelastography: one size does not fit all. Seminars in
thrombosis and hemostasis. 2010; 36: 699-7.
Use of recovery phase kinetics following cardiopulmonary 
exercise testing to predict postoperative complications and 
1-year mortality after major intra-abdominal cancer surgery
Dr Michael Li (Peter MacCallum Cancer Centre, Melbourne,
Victoria), Prof Kwok-Ming Ho (Royal Perth Hospital, University
of Western Australia, Murdoch University, Perth, Western
Australia), Dr Amelie Muellem (University of Cologne,
Germany), Dr Luis Cuadros (Peter MacCallum Cancer Centre),
Mr Jarrod Basto (Peter MacCallum Cancer Centre), Dr
Hilmy Ismail (Peter MacCallum Cancer Centre, University of
Melbourne), Prof Robert Schier (University of Cologne), Prof
Bernhard Riedel (Peter MacCallum Cancer Centre, University
of Melbourne)
Introduction: Over the past decade, cardiopulmonary
exercise testing (CPET) – especially oxygen consumption
at Anaerobic Threshold (AT) and at peak exercise (pVO2) –
have been studied for preoperative risk stratification. Less
attention has been given to significance of CPET parameters
during the recovery phase. Studies have shown that
impaired chronotropic response to exercise is associated
with an increased risk of morbidity after abdominal surgery.
1. Similarly, impaired speed of heart rate recovery (HRR)
to baseline following a 6-minute walk test has also been
reported to associate with increased risk of complications
following lung cancer resection. 2. This study aimed to
assess whether a slower HRR after exercise – a marker
of parasympathetic dysfunction – is (a) associated with
an increased risk of postoperative morbidity and 1-year
mortality after major cancer surgery, and (b) better than
other recovery kinetics in predicting these two clinical
outcomes.
Methods: The ability of the following recovery kinetic
parameters, including changes in HRR, oxygen uptake
(VO2R), mixed expired CO2 (PeCO2), end-tidal CO2 (PETCO2),
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and minute ventilation to carbon dioxide ratio (Ve/VCO2) 
measured from the time when peak exercise capacity was 
achieved to the 1st, 2nd, 3rd, 4th and 5th minutes after 
cessation of exercise, to predict postoperative morbidity and 
1-year mortality after major cancer surgery was assessed in
this retrospective cohort study. PeCO2 was calculated using
the Hansen method by dividing 863 by the Ve/VCO2 slope.
Area under the receiver-operating-characteristic (AUROC)
curve was used to evaluate the ability of the recovery
kinetics to discriminate between patients with and without
postoperative morbidity (Grade III or higher Clavien-Dindo
complications) and 1-year survival.
Results: Of the 80 consecutive patients who had had major
intra-abdominal cancer surgery between September 2013
and August 2015, 13 (16%) patients died upon follow-up.
The HRR and VO2R slopes were both significantly different
between survivors and non-survivors, with a modest ability
to predict 1-year survival (HRR: AUROC 0.74, 95% confidence
interval [CI] 0.59-0.89, p=0.002; and VO2R: AUROC 0.74,
95%CI 0.61-0.86, p=0.008). The post-exercise recovery
kinetics for CO2 exchange parameters (PETCO2, PeCO2, Ve/
VCO2) were not significantly different between survivors
and non-survivors. None of the recovery kinetic parameters
including HRR were predictive of high grade postoperative
morbidities.
Conclusions: This small pilot study showed that both the rate
of recovery of the heart rate (HRR) and oxygen consumption
(VO2R) after maximal exercise were modest predictors for
medium-term survival after major intra-abdominal cancer
surgery but not major postoperative complications. Whether
combining these two recovery kinetic parameters with
the standard CPET variables, such as AT and pVO2, would
enhance the overall predictive ability of CPET is unknown and
warrants further investigation. Whether HRR can outperform
other markers of parasympathetic function such as heart rate
variability is also uncertain but deserves comparative studies.
References: 1. Hightower CE, et al. Br J Anaesth
2010;104:465-71. 2. Ha D, et al. J Thorac Cardiovasc Surg
2015;149:1168-73.
A two-year retrospective review of the predictors of 
pulmonary morbidity following rib fracture at a tertiary 
metropolitan hospital
Dr Nicholas Lightfoot (Middlemore Hospital, Auckland, New 
Zealand), Dr Ashley Scott (Northumbria NHS Foundation Trust, 
United Kingdom), Dr Anna Rainey (Auckland City Hospital, 
Auckland, New Zealand), Ms Hannah Widjaja (University 
of Auckland, Auckland, New Zealand), Mr Kevin Henshall 
(Middlemore Hospital), Dr Andrew  Cameron (Middlemore 
Hospital)
Introduction: Blunt chest trauma leading to rib fracture is 
a common trauma induced injury. In addition to significant 
pain, patients are at risk of adverse events such as post-
traumatic pneumonia, mechanical ventilation or death. Those 
who are more than 65 years of age, who have sustained 
poly-trauma or multiple fractures are at an elevated risk of 
rib fracture induced morbidity and mortality. Following a 
death after isolated thoracic trauma in an older patient at our 
institution, we have reviewed our management strategies and 
outcomes. We hope to determine the predictors of adverse 
pulmonary events on patient presentation to hospital to help 
further refine our pathways of care.
Methods: Hospital Research Office approval was obtained 
prior to study conduct. Patients presenting to our institution 
between the 1st January 2015 and the 31st December 2016 
with clinical or radiological evidence of rib fracture were 
identified from a trauma database and electronic review of 
radiology reports. The primary outcome was the occurrence 
of pulmonary morbidity, defined as either pneumonia or 
the need for ventilatory support during the index hospital 
admission. Univariate logistic regression was used to 
identify predictors of pulmonary morbidity on presentation 
to hospital. From these results a multivariate model was 
developed. The performance of the model was assessed 
through visual inspection and calculation of the area under 
a ROC curve. Continuous parameters are presented as mean 
(± standard deviation) or median (interquartile range) as 
appropriate and number (percent) for categorical data. 
Statistical tests were two-tailed with p<0.05 for significance. 
Results: During the study period 293 patients presented with 
rib fractures. There were 224 males (76.5%) and 69 females 
(23.5%). Thirty-two patients (10.9%) experienced pulmonary 
morbidity. These patients were older (70 (33) years versus 
50 (28), p<0.001), with a greater Charlson score (3 (4) versus 
1 (2), p=0.001) and had experienced a greater number of 
fractures (5 (3) versus 3 (3), p=0.004). The Length of Stay 
was greater in patients with pulmonary morbidity (11.4 
(16.3) days versus 4.0 (6.0), p<0.001). There were significant 
differences in the rate of Critical Care Unit admission (31.3% 
versus 15.4%, p=0.03) and mortality at 60 days (21.9% 
versus 3.1% p<0.001). On multivariate modelling factors 
predictive of pulmonary morbidity were age (Odds Ratio 
(OR) 1.1, 95th% Confidence Interval 1.03 – 1.17, p=0.003), 
baseline platelet count (OR 1.01, 1.00 – 1.01, p=0.03), 
baseline albumin (OR 0.87, 0.79 – 0.95, p=0.003), baseline 
creatinine (OR 1.02, 1.00 – 1.03, p=0.02), baseline presence 
of respiratory comorbidity (OR 4.6, 1.2 – 17.5, p=0.02) and 
the Charlson Comorbidity Index (OR 2.1, 1.1 – 3.8, p=0.02). 
The predictive model generated for pulmonary morbidity had 
an area under the ROC curve of 0.743 (95th% Confidence 
Interval 0.662 – 0.824). At their point of maximisation, the 
sensitivity was 0.906 and the specificity 0.479, this yielded a 
positive predictive value of 0.176 and a negative predictive 
value of 0.977. 
Conclusion: In this series we have shown that rib fractures 
are associated with serious morbidity and at times mortality. 
We will use our model to standardise care and optimise 
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referral for advanced pain management and Critical Care 
review. Moving forward we will further validate our model 
and use this information to generate a score to help predict 
patient morbidity
The predictors hyponatraemia following elective primary 
unilateral knee arthroplasty at a tertiary hospital. A 
retrospective review and predictive model
Dr Nicholas Lightfoot (Middlemore Hospital, Auckland, 
New Zealand), Mr Navneet Singh (University of Auckland, 
Auckland, New Zealand), Dr Julian Dimech (Middlemore 
Hospital), Dr Nicholas  Gormack (Counties Manukau 
District Health Board, Auckland, New Zealand), Dr Joyce Tai 
(Middlemore Hospital), Dr Andrew  Cameron (Middlemore 
Hospital)
Introduction: Knee arthroplasty is a commonly performed 
procedure. There has been a drive to standardise care 
such that patient recovery can be accelerated leading to 
reductions in hospital length of stay. Others have reported 
as to the impact of delirium, constipation and nausea on 
length of stay after hip and knee arthroplasty. Little has 
been written about the impact of disorders of electrolyte 
balance in patients undergoing total joint arthroplasty. We 
hope to determine the rate of hyponatraemia in patients 
who have undergone knee arthroplasty at our institution 
and to elucidate any association between hyponatraemia 
and hospital length of stay, alternations in patient specific 
recovery metrics and complication profiles.
Methods: University and Hospital Research Ethics approval 
was obtained prior to study conduct. Patients who 
underwent elective primary total knee arthroplasty (TKA) at 
our institution between the 1st January and 31st December 
2014 were retrospectively enrolled. Fluid balance and 
laboratory data was manually extracted from clinical records 
and merged with a pre-existing Departmental TKA database. 
The primary outcome was the occurrence of hyponatraemia 
(defined as a sodium level of less than 135mmol/L) during 
the first three post-operative days. Demographic and 
outcome data were reported for the two groups. Univariate 
then multivariate logistic regression with demographic, 
operative, laboratory and pharmaceutical data were then 
used to identify significant predictors of post-operative 
hyponatremia. Continuous parameters are presented as 
mean (± standard deviation, SD) or median (interquartile 
range, IQR) as appropriate and number (percent) for 
categorical data. Statistical tests were two-tailed with p<0.05 
for significance. 
Results: Two-hundred and thirty-six patients underwent 
primary unilateral TKA during the study period. There were 
97 (41.1%) males and 139 (58.9%) females. One-hundred 
and seven (45.3%) patients experienced hyponatraemia 
within the first three post-operative days. These patients 
were older than those who maintained normal sodium levels 
(70 (IQR 13) versus 65 (12) years, p<0.001). For those who 
experienced hyponatraemia, the hospital length of stay was 
marginally, but significantly prolonged (4.3 (2.1) versus 4.1 
(1.8) days, p=0.04). There was no difference between the Day 
One (p=0.82) and Day Two (p=0.12) Quality of Recovery-15 
scores between those with hyponatraemia and a normal 
sodium level. Differences in the time to assisted weight 
bearing following surgery (p=0.35) and thirty-day readmission 
rate (p=0.10) were again insignificant. Predictors of 
hyponatraemia within the first three post-operative days on 
multivariate modelling were operative duration (Odds Ratio 
(OR) 0.98, 95th% Confidence Interval 0.97 – 1.00, p=0.04), 
loop diuretic use (OR 6.2, 1.5 – 25.6, p=0.01), thiazide 
diuretic use (OR 3.3, 1.2 – 9.0, p=0.02) and a preoperative 
sodium level of 140-145mmol/L (OR 0.09, 0.02 – 0.48, 
p=0.01). Total oral fluid intake during the first three days was 
not predictive (p=0.06).
Conclusion: Hyponatraemia is a common finding 
following TKA. This led to prolongation of length of stay of 
approximately five hours. This may be clinically insignificant 
by itself but when combined with other factors could 
present an opportunity to attain gains in productivity. We 
will continue to modify our predictive model with the aim to 
reduce hyponatraemia in this population.
Haemoglobin rise during separation from cardiopulmonary 
bypass in adults: a prospective observational study
Dr Dash Newington (The Prince Charles Hospital, Brisbane, 
Queensland), Mrs Nicole Tysoe (The Prince Charles Hospital)
Introduction: At our institution we noticed that haemoglobin 
(Hb) levels often rise sharply during separation from 
cardiopulmonary bypass. We designed a study to determine 
if this Hb rise consistently occurs and the magnitude of 
any increase. Such knowledge may reduce unnecessary 
intraoperative red cell transfusion in cardiothoracic surgical 
patients.
Methods: The study was designed to detect a 2g/L Hb 
difference with a significance of p<0.05 and a power of 
80%. All adult patients undergoing elective or emergency 
cardiopulmonary bypass procedures at our institution 
between 28/12/2017 and 25/01/2018 were recruited. 
A baseline blood gas was collected prior to initiation of 
cardiopulmonary bypass. At the end of each bypass run, after 
rewarming, an arterial blood gas was taken from the bypass 
pump. A simultaneous sample taken from the patient’s 
arterial line was also processed for comparison. A subsequent 
intraoperative blood gas was taken after separation from 
cardiopulmonary bypass at a time determined by the 
treating anaesthetist. A study form was completed for each 
patient recording: age, body mass index, surgical procedure, 
baseline albumin and creatinine, bypass duration, if diuretics 
were given, if haemofiltration was used, and details of any 
fluid or blood products administered by the anaesthetist 
or perfusionist between the final bypass blood gas and the 
first gas collected after separation from bypass. Blood gas 
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samples were processed on one of two Radiometer ABL800 
Flex machines. The machine used to analyse each sample was 
documented.
Results: 72 patients were included in the study (sample 
size calculation of 64 plus a 10% margin of safety). Patient 
age ranged from 16-83 years. Surgical procedures included 
coronary artery bypass grafting, valve surgery, aortic surgery, 
adult congenital procedures, atrial myxoma resection, 
insertion of heartware, pulmonary thromboendarterectomy, 
and heart and lung transplants. The median bypass duration 
was 76 mins. Hb difference from the final bypass sample 
to the first sample after separation from bypass ranged 
from a 5g/L decrease to a 34g/L increase. 64 patients 
(89%) demonstrated a Hb rise, with 14 patients (19%) 
demonstrating a rise of 10g/L or greater. The data did not 
have a normal distribution (skewness 1.679, kurtosis 5.218). 
The median Hb increase was 5.5g/L (IQR 2.0-9.0, Z -.6831 
p <0.001) and the mean increase was 6.33g/L (95% CI 4.87-
7.80, p<0.01) over a median duration of 27 minutes (SD 
16.758). This occurred despite 21 patients (29%) having 
received crystalloid (mean 410ml) during separation from 
bypass and only 3 patients (4%) having received either 
packed red cells, haemofiltered pump blood or cell-saver 
blood (mean 300ml). There was no significant correlation 
between Hb difference and the time lapse between samples, 
duration of cardiopulmonary bypass, or baseline albumin 
or creatinine levels. There was a weak positive correlation 
(r = 0.239, sig. 2-tailed 0.004) between baseline Hb and Hb 
difference. Hb levels measured from simultaneous samples 
taken from the bypass pump and patient’s arterial line, and 
from the two machines used to process the samples did not 
significantly differ.
Conclusions: The majority of patients showed a statistically 
and clinically significant increase in Hb during separation from 
bypass. Further studies are warranted to establish why this 
increase in Hb occurs and to better characterise and predict 
subgroups of patients who do not respond as expected.
The effect of a pulmonary bundle of care on postoperative 
pulmonary complications: A quality improvement project
Dr David Shan (Peter MacCallum Cancer Centre, University 
of Melbourne, Melbourne, Victoria), Dr Rani Chahal (Peter 
MacCallum Cancer Centre, University of Melbourne), Dr 
Hilmy Ismail (Peter MacCallum Cancer Centre, University of 
Melbourne), Ms Jamie Waterland (Peter MacCallum Cancer 
Centre, University of Melbourne), Professor Bernhard Riedel 
(Peter MacCallum Cancer Centre, University of Melbourne)
Introduction: Enhanced Recovery After Surgery (ERAS), a 
multimodal perioperative care pathway, aims to achieve 
early functional recovery following major surgery. Despite 
the widespread delivery of ERAS, postoperative pulmonary 
complications (PPC) remain a common cause of postoperative 
morbidity and mortality. Reported incidence of PPC (2%-
40%) is dependent on patient risk factors and surgical 
complexity. Following a baseline prevalence audit, we added 
a multidisciplinary respiratory care bundle to our ERAS 
program to specifically target PPC. This pulmonary package, 
“iCOUGH”, adapted from that piloted at Central Manchester 
University Hospital (UK) [1], combines Incentive spirometry, 
Cough/deep breathing, Oral care, Understanding education, 
Get-out-of-bed and Head-of-bed elevation. We implemented 
iCOUGH within a typical quality improvement framework of 
OODA (observe, orientate, decide, act) loops. 
Methods: We evaluated the baseline incidence of PPC over 
a two-month period (observe: April–May 2017). Patients 
included those undergoing major (≥2hours) elective upper 
gastrointestinal, colorectal, and head and neck cancer 
surgery with an intermediate-to-high baseline risk of PPC. 
The ARISCAT (Assess Respiratory Risk in Surgical Patients in 
CATalonia) score, a validated predictive index of PPC assessed 
baseline risk [2]. ARISCAT scores of 26-44 and ≥45 defined 
patients at intermediate and high risk of PPC respectively. 
We adapted (orientate-decide) the iCOUGH intervention to 
include the Active Cycle of Breathing Technique (aCOUGH), 
and then implemented (act) across a similar cohort of 
patients that were identified during preoperative anaesthetic 
clinic visits. The aCOUGH bundle was re-emphasised 
during patient educational ‘Surgery School (SS)’ sessions 
(led by perioperative staff) and on ward visits. Compliance 
to aCOUGH components and incidence of PPC were then 
monitored prospectively (June–November 2017) in all eligible 
patients (re-observe). A monthly run-chart was created to 
display the ongoing compliance with aCOUGH against the 
incidence of PPC. 
Results: Bundle compliance (≥3 components) rates increased 
from 56.4% to 78.9% (p=0.01) over the first six months of 
implementation. Following step-wise delivery of aCOUGH, 
and after six months of implementation (October–November 
2017; n=71) the overall PPC rates reduced from a baseline 
rate of 43.6% to 26.8% (17/39 vs. 19/71; p=0.07) but this 
did not achieve statistical significance. In the subgroup with 
highest risk of PPC (ARISCAT score≥45) the rate was reduced 
significantly from 83.3% to 16.7% (5/6 vs. 1/6; p=0.02). This 
reduction in PPC did not achieve statistical significance in 
intermediate risk patients, with a reduction from a baseline 
incidence of 36.4% to 27.7% (12/33 vs. 18/65; p=0.38). 
Conclusion: The aCOUGH bundle of care resulted in a 
significant reduction in PPC rates in high-risk patients. 
Our preliminary data supports the ongoing aCOUGH 
program, which in conjunction with our SS holds promise 
to significantly reduce PPC in at-risk surgical patients. This 
program also has the potential to improve patient satisfaction 
through patient engagement during the peri-operative 
period. Sustained improvement in PPC rate is expected as 
components of aCOUGH become refined (by using OODA 
loops) and self-sufficient (embedded into the clinical culture) 
through ongoing clinician feedback.
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Programmed intermittent bolus administration of local 
anaesthetic provides superior analgesia compared with 
continuous infusion via extra-pleural catheters following 
thoracic surgery: A retrospective analysis
Dr Luke Willshire (Austin Health, Melbourne, Victoria), Dr 
Matthew Kilpin (Austin Health), Dr Bridget Bishop (Austin 
Health), Dr Brett  Pearce (Austin Health)
Introduction: Surgically sited extra-pleural local anaesthetic 
(LA) catheters are an effective method of analgesia 
for patients following thoracotomy and video-assisted 
thoracoscopic surgery (VATS). However, there is no consensus 
in the literature as to the most beneficial regimen of 
LA delivery. Our objective was to determine whether a 
programmed intermittent bolus (PIB) technique provides 
superior analgesia via an extra-pleural catheter following 
thoracic surgery when compared to a continuous LA infusion 
regimen. 
Methods: We performed a retrospective, single-centred, 
observational study assessing 87 adult patients who received 
an extra-pleural catheter following VATS or thoracotomy. 
Data were collected from our institution’s scanned medical 
record. Patients were excluded if they underwent multiple 
procedures, had an oesophagectomy or were opioid tolerant. 
All patients received a surgically sited extra-pleural catheter. 
Patients were stratified into two groups based on the 
percentage of their total daily ropivacaine dose they received 
as boluses: Controls (<10%; n=29) and PIB (≥10%; n=55). 
Our primary outcome was Oral Morphine Equivalent Daily 
Dose (OMEDD) consumption day one post-thoracic surgery. 
Secondary outcomes included OMEDD consumption on days 
two and three post-operation, pain scores via the Numeric 
Rating Scale, daily ketamine use, and daily ropivacaine dose. 
Prospective subgroup analysis was performed comparing 
Low-Dose PIB (10-<25%; n=34) and High-Dose PIB (≥25%; 
n=21) against Controls.
Results: There was no difference between groups in age, 
weight, gender, BMI and type of surgery. The PIB group had 
lower mean OMEDD consumption on each day post-thoracic 
surgery compared to Controls, which was significant on day 
three (day one mean difference (95% CI): 44.1mg (-8.5 – 
96.9), p = 0.10; day two: 47.3mg (-5.2 – 99.7), p = 0.08; day 
three: 98.1mg (39.7 – 156), p = 0.001). There was a reduction 
in the number of patients requiring ketamine infusions in 
the PIB group compared with Controls on each day. This was 
statistically significant on days two (p = 0.02) and three (p = 
0.04). There was a small difference in maximum pain scores 
favouring the PIB group which was not statistically significant. 
There was no difference in total ropivacaine dose. Subgroup 
analysis demonstrated a consistently greater effect for the 
High-Dose PIB group compared with the Low-Dose PIB group. 
The High-Dose PIB group had a greater reduction in OMEDD 
use on all days when compared with Controls; this was 
significant on days two and three (day one mean difference 
(95% CI): 41mg (-31.7 – 113.7), p = 0.26; day two: 69.3mg 
(6.3 – 132.2), p = 0.03; day three: 114mg (40.5 – 188), p = 
0.003). 
Conclusion: Our study has demonstrated a reduction in 
OMEDD use with PIB via extra-pleural catheters for three 
days post-thoracic surgery, which was significant on day 
three. There was also a concomitant reduction in ketamine 
use and no difference in pain scores or ropivacaine dose. This 
effect was dose dependant, being more evident in the High-
Dose PIB group. Overall, PIB, particularly in higher doses, 
appears to provide superior analgesia to continuous infusion 
when administered via an extra-pleural catheter in thoracic 
surgery.
Volatile anaesthesia and perioperative outcomes related 
to cancer (VAPOR C): An interim report of a feasibility study 
for an international, multi-centre, prospective RCT
Dr Ken Yee (Peter MacCallum Cancer Centre, Melbourne, 
Victoria), Dr Julia Dubowitz (Royal Melbourne Hospital, 
Melbourne, Victoria), Dr David Shan (Peter MacCallum 
Cancer Centre), Professor Bernhard Riedel (Peter MacCallum 
Cancer Centre), Dr Jonathan Hiller (Peter MacCallum Cancer 
Centre), Dr Hilmy Ismail (Peter MacCallum Cancer Centre), Dr 
Alexander Heriot (Peter MacCallum Cancer Centre), Dr Erica 
Sloan (Peter MacCallum Cancer Centre)
Background: Currently, it is estimated that more than 
80% of cancer patients require anaesthesia for either 
definitive cancer resection or diagnostic, supportive and 
palliative procedures. General anaesthesia for surgery can 
be delivered as either volatile-based general anaesthesia 
or as total intravenous anaesthesia (TIVA) using propofol. 
Both techniques are used routinely in clinical practice and 
are interchangeable according to anaesthetist preference. 
Preliminary studies suggest that TIVA with propofol and/
or neuraxial anaesthesia associate with favourable cancer 
outcomes. Additionally, anti adrenergic, anti inflammatory 
strategies including adjunct therapies like non selective 
β blockers and non steroidal anti inflammatory drugs are also 
associated with improved cancer outcomes. In contrast, 
volatile anaesthetic agents may adversely amplify adaptive 
and pro survival transcriptional (HIF 1α/β and PI3K/Akt/
mTOR mediated) pathways to accelerate cancer growth. 
As such, our current anaesthetic techniques may modulate 
these processes to adversely impact on the global burden of 
disease related to cancer. We conducted a feasibility study 
toward conducting a phase IV, international, multi-centre, 
single blind, randomised control trial (VAPOR-C).
Methods: Patients scheduled for elective, major resection 
of cancers are currently being recruited and randomised 
to either volatile or propofol TIVA general anaesthesia. The 
feasibility trial will measure the ability to recruit eligible 
patients into the study with the criteria of a recruitment 
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rate of at least 75% to be considered feasible. The study 
protocol will also be assessed as feasible if a successful 
delivery rate of at least 90% of either anaesthetic technique 
is achieved. Data collection and analysis will be performed to 
refine the primary endpoints for the larger VAPOR-C study. 
These endpoints will relate to: Recurrence-free survival, 
postoperative morbidity and mortality and quality of life 
outcomes.
Results: Screening commenced on 21/8/2017, and the trial 
has been active for 93 days or 3 months. Of the 255 patients 
screened from pre-anaesthetic clinic (PAC) and elective 
theatre lists using the criteria of patient age, cancer, type 
and stage of cancer 93 patients (36%) met the selection 
criteria. Of these 93 patients, 66 patients were approached 
for recruitment and 51 agreed to participate in the trial. 
The 27 patients that were eligible but were not approached 
for the trial were either too ill at the time of screening, the 
incorrect cancer type or the research team was unavailable. 
15 patients refused to participate and two patients were 
considered not appropriate by the treating anaesthetist. The 
trial achieved a recruitment rate of 77% of eligible patients 
with 100% of delivery rate of either anaesthetic technique in 
all procedures undertaken. Reasons for patients not meeting 
the selection criteria primarily included: incorrect surgical 
procedure length/type of surgery, metastatic disease or non-
English speaking background. A total of 103 blood biomarker 
time points have been collected to date and will be batched 
for analysis (CTCs, cytokines, cDNA, flow cytometry) later to 
identify the most sensitive time points and clinically relevant 
biomarkers on which the large VAPOR-C trial will focus. 
Discussion: The trial is currently on track to achieve the 
required feasibility criteria at Peter MacCallum with several 
refinements made to the Vapor-C protocol, so that this trial 
can be performed at future national and international sites. 
